• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗抵抗性抑郁症的诊断与管理方法。

Approach to Diagnosis and Management of Treatment-Resistant Depression.

机构信息

Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9119, USA.

Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9119, USA; Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9119, USA.

出版信息

Psychiatr Clin North Am. 2023 Jun;46(2):247-259. doi: 10.1016/j.psc.2023.02.011. Epub 2023 Mar 27.

DOI:10.1016/j.psc.2023.02.011
PMID:37149343
Abstract

Major depressive disorder is a chronic and recurrent illness that affects 20% of adults during their lifetime and is one of the leading causes of suicide in the United States. A systematic measurement-based care approach is the essential first step in the diagnosis and management of treatment-resistant depression (TRD) by promptly identifying individuals with depression and avoiding delays in treatment initiation. As comorbidities may be associated with poorer outcomes to commonly used antidepressants and increase risk of drug-drug interactions, their recognition and treatment is an essential component of management of TRD.

摘要

重度抑郁症是一种慢性且反复发作的疾病,终生中有 20%的成年人会受到影响,它也是美国导致自杀的主要原因之一。通过及时识别抑郁症患者并避免治疗启动的延迟,系统的基于测量的护理方法是诊断和管理治疗抵抗性抑郁症(TRD)的基本第一步。由于共病可能与常用抗抑郁药的疗效较差相关,并增加药物相互作用的风险,因此识别和治疗共病是 TRD 管理的重要组成部分。

相似文献

1
Approach to Diagnosis and Management of Treatment-Resistant Depression.治疗抵抗性抑郁症的诊断与管理方法。
Psychiatr Clin North Am. 2023 Jun;46(2):247-259. doi: 10.1016/j.psc.2023.02.011. Epub 2023 Mar 27.
2
Treatment-resistant depression in primary care across Canada.加拿大初级保健中的治疗抵抗性抑郁症。
Can J Psychiatry. 2014 Jul;59(7):349-57. doi: 10.1177/070674371405900702.
3
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.中国伴有焦虑与不伴焦虑的治疗抵抗性抑郁症患者缓解率的差异:OPERATION 研究报告。
J Affect Disord. 2013 Sep 25;150(3):834-9. doi: 10.1016/j.jad.2013.03.012. Epub 2013 Apr 6.
4
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?针对抑郁患者治疗抵抗的临床方法:当常规治疗效果不够好时该怎么办?
World J Biol Psychiatry. 2021 Sep;22(7):483-494. doi: 10.1080/15622975.2020.1851052. Epub 2020 Dec 8.
5
Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.一项为期 13 年的全国性队列研究调查了早期和终生临床特征及共病对治疗抵抗性抑郁症发展风险的影响。
BMC Psychiatry. 2020 Nov 17;20(1):541. doi: 10.1186/s12888-020-02935-z.
6
The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.美国治疗抵抗性抑郁症和重度抑郁症的患病率和国家负担。
J Clin Psychiatry. 2021 Mar 16;82(2):20m13699. doi: 10.4088/JCP.20m13699.
7
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.在一项基于人群的研究中,治疗抵抗性抑郁症与患者结局和医疗资源利用的关系。
JAMA Psychiatry. 2023 Feb 1;80(2):167-175. doi: 10.1001/jamapsychiatry.2022.3860.
8
Defining treatment-resistant depression: a comprehensive review of the literature.难治性抑郁症的定义:文献综述
Ann Clin Psychiatry. 2014 Aug;26(3):222-32.
9
Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.丹麦重度抑郁症患者中治疗抵抗性抑郁症患者的治疗模式。
J Affect Disord. 2021 May 15;287:204-213. doi: 10.1016/j.jad.2021.03.029. Epub 2021 Mar 17.
10
Challenges of Treatment-resistant Depression.难治性抑郁症的挑战
Psychiatr Danub. 2018 Sep;30(3):273-284. doi: 10.24869/psyd.2018.273.

引用本文的文献

1
Disease burden and attributable risk factors of major depressive disorder in China, Japan, and South Korea from 1990 to 2021 and its prediction to 2035.1990年至2021年中国、日本和韩国重度抑郁症的疾病负担、归因风险因素及其到2035年的预测。
Front Public Health. 2025 Apr 14;13:1510091. doi: 10.3389/fpubh.2025.1510091. eCollection 2025.
2
Intranasal dantrolene nanoparticles inhibit lipopolysaccharide-induced depression and anxiety behavior in mice.鼻内给予丹曲林纳米颗粒可抑制脂多糖诱导的小鼠抑郁和焦虑行为。
Res Sq. 2025 Apr 3:rs.3.rs-6254774. doi: 10.21203/rs.3.rs-6254774/v1.
3
Is Artificial Intelligence the Next Co-Pilot for Primary Care in Diagnosing and Recommending Treatments for Depression?
人工智能会成为基层医疗诊断和推荐抑郁症治疗方案的下一个辅助工具吗?
Med Sci (Basel). 2025 Jan 11;13(1):8. doi: 10.3390/medsci13010008.